328 related articles for article (PubMed ID: 30902924)
1. Glioblastoma heterogeneity and the tumour microenvironment: implications for preclinical research and development of new treatments.
Perrin SL; Samuel MS; Koszyca B; Brown MP; Ebert LM; Oksdath M; Gomez GA
Biochem Soc Trans; 2019 Apr; 47(2):625-638. PubMed ID: 30902924
[TBL] [Abstract][Full Text] [Related]
2. Molecular crosstalk between tumour and brain parenchyma instructs histopathological features in glioblastoma.
Bougnaud S; Golebiewska A; Oudin A; Keunen O; Harter PN; Mäder L; Azuaje F; Fritah S; Stieber D; Kaoma T; Vallar L; Brons NH; Daubon T; Miletic H; Sundstrøm T; Herold-Mende C; Mittelbronn M; Bjerkvig R; Niclou SP
Oncotarget; 2016 May; 7(22):31955-71. PubMed ID: 27049916
[TBL] [Abstract][Full Text] [Related]
3. Extracellular proteolysis in glioblastoma progression and therapeutics.
Quesnel A; Karagiannis GS; Filippou PS
Biochim Biophys Acta Rev Cancer; 2020 Dec; 1874(2):188428. PubMed ID: 32956761
[TBL] [Abstract][Full Text] [Related]
4. Adaptive Changes of Glioblastoma Cells Following Exposure to Hypoxic (1% Oxygen) Tumour Microenvironment.
Musah-Eroje A; Watson S
Int J Mol Sci; 2019 Apr; 20(9):. PubMed ID: 31035344
[TBL] [Abstract][Full Text] [Related]
5. The emergent role of exosomes in glioma.
Gourlay J; Morokoff AP; Luwor RB; Zhu HJ; Kaye AH; Stylli SS
J Clin Neurosci; 2017 Jan; 35():13-23. PubMed ID: 27771233
[TBL] [Abstract][Full Text] [Related]
6. Tumor microenvironment tenascin-C promotes glioblastoma invasion and negatively regulates tumor proliferation.
Xia S; Lal B; Tung B; Wang S; Goodwin CR; Laterra J
Neuro Oncol; 2016 Apr; 18(4):507-17. PubMed ID: 26320116
[TBL] [Abstract][Full Text] [Related]
7. Modeling the Interaction between the Microenvironment and Tumor Cells in Brain Tumors.
Pasqualini C; Kozaki T; Bruschi M; Nguyen THH; Minard-Colin V; Castel D; Grill J; Ginhoux F
Neuron; 2020 Dec; 108(6):1025-1044. PubMed ID: 33065047
[TBL] [Abstract][Full Text] [Related]
8. The Invasive Region of Glioblastoma Defined by 5ALA Guided Surgery Has an Altered Cancer Stem Cell Marker Profile Compared to Central Tumour.
Smith SJ; Diksin M; Chhaya S; Sairam S; Estevez-Cebrero MA; Rahman R
Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29156557
[TBL] [Abstract][Full Text] [Related]
9. Immune Microenvironment in Glioblastoma Subtypes.
Chen Z; Hambardzumyan D
Front Immunol; 2018; 9():1004. PubMed ID: 29867979
[TBL] [Abstract][Full Text] [Related]
10. The tumour microenvironment, treatment resistance and recurrence in glioblastoma.
White J; White MPJ; Wickremesekera A; Peng L; Gray C
J Transl Med; 2024 Jun; 22(1):540. PubMed ID: 38844944
[TBL] [Abstract][Full Text] [Related]
11. Glioblastoma preclinical models: Strengths and weaknesses.
Pasupuleti V; Vora L; Prasad R; Nandakumar DN; Khatri DK
Biochim Biophys Acta Rev Cancer; 2024 Jan; 1879(1):189059. PubMed ID: 38109948
[TBL] [Abstract][Full Text] [Related]
12. Challenges in glioblastoma immunotherapy: mechanisms of resistance and therapeutic approaches to overcome them.
Habashy KJ; Mansour R; Moussalem C; Sawaya R; Massaad MJ
Br J Cancer; 2022 Oct; 127(6):976-987. PubMed ID: 35662275
[TBL] [Abstract][Full Text] [Related]
13. Multidimensional communication in the microenvirons of glioblastoma.
Broekman ML; Maas SLN; Abels ER; Mempel TR; Krichevsky AM; Breakefield XO
Nat Rev Neurol; 2018 Aug; 14(8):482-495. PubMed ID: 29985475
[TBL] [Abstract][Full Text] [Related]
14. Astrocyte immunometabolic regulation of the tumour microenvironment drives glioblastoma pathogenicity.
Perelroizen R; Philosof B; Budick-Harmelin N; Chernobylsky T; Ron A; Katzir R; Shimon D; Tessler A; Adir O; Gaoni-Yogev A; Meyer T; Krivitsky A; Shidlovsky N; Madi A; Ruppin E; Mayo L
Brain; 2022 Sep; 145(9):3288-3307. PubMed ID: 35899587
[TBL] [Abstract][Full Text] [Related]
15. Role of extracellular vesicles in glioma progression.
Quezada C; Torres Á; Niechi I; Uribe D; Contreras-Duarte S; Toledo F; San Martín R; Gutiérrez J; Sobrevia L
Mol Aspects Med; 2018 Apr; 60():38-51. PubMed ID: 29222067
[TBL] [Abstract][Full Text] [Related]
16. Tumor-derived fibulin-3 activates pro-invasive NF-κB signaling in glioblastoma cells and their microenvironment.
Nandhu MS; Kwiatkowska A; Bhaskaran V; Hayes J; Hu B; Viapiano MS
Oncogene; 2017 Aug; 36(34):4875-4886. PubMed ID: 28414309
[TBL] [Abstract][Full Text] [Related]
17. Kinins in Glioblastoma Microenvironment.
Oliveira MN; Breznik B; Pillat MM; Pereira RL; Ulrich H; Lah TT
Cancer Microenviron; 2019 Dec; 12(2-3):77-94. PubMed ID: 31420805
[TBL] [Abstract][Full Text] [Related]
18. Astrocytes, the rising stars of the glioblastoma microenvironment.
Brandao M; Simon T; Critchley G; Giamas G
Glia; 2019 May; 67(5):779-790. PubMed ID: 30240060
[TBL] [Abstract][Full Text] [Related]
19. 3D extracellular matrix interactions modulate tumour cell growth, invasion and angiogenesis in engineered tumour microenvironments.
Taubenberger AV; Bray LJ; Haller B; Shaposhnykov A; Binner M; Freudenberg U; Guck J; Werner C
Acta Biomater; 2016 May; 36():73-85. PubMed ID: 26971667
[TBL] [Abstract][Full Text] [Related]
20. The mode and dynamics of glioblastoma cell invasion into a decellularized tissue-derived extracellular matrix-based three-dimensional tumor model.
Koh I; Cha J; Park J; Choi J; Kang SG; Kim P
Sci Rep; 2018 Mar; 8(1):4608. PubMed ID: 29545552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
